Indogulf Cropsciences Limited (IGCL) — Offer Document | 11 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Monitoring agency confirms no deviation in IPO fund utilization
🔄 What Changed
Rs 200 crore IPO proceeds fully deployed across cost items with zero material deviation
💡 Investor Takeaway
Shareholders can view strict oversight of IPO fund use ensuring no misuse of capital

Indogulf Cropsciences Limited received a monitoring agency report from Brickwork Ratings confirming no deviation in the utilization of Rs 200 crore raised through a fresh issue and offer for sale. The report details fund deployment across cost items like land, plant, and working capital, with actual spending aligning with approved objects. No material deviations were observed, and all statutory approvals remain in place. The filing underscores compliance with SEBI ICDR norms for IPO proceeds tracking.

📄 View Original Announcement (PDF)

About Indogulf Cropsciences Limited (IGCL)

Chemicals · Agro Chemicals · Listed on NSE

Market Cap: ₹450.22 Cr P/E: 13.8 ROE: 14.0% ROCE: 14.0%

View full IGCL stock details →

📡 Get AI alerts when IGCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track IGCL — Free

📊 More IGCL filings

See all IGCL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when IGCL files new disclosures

Track IGCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track IGCL — Free

Free account · 2 AI queries/day